Tourmaline Bio is a clinical-stage biopharmaceutical company developing pacibekitug, an anti-IL-6 mAb, as a treatment option for atherosclerotic cardiovascular disease Pacibekitug is a promising targeted therapy with the potential to reduce systemic inflammation—an independent and significant driver of cardiovascular risk—addressing a
Transaction expands Electric Hydrogen’s co-development and financing solutions for customers Electric Hydrogen, a U.S. manufacturer of advanced electrolyzers, announced it has acquired Ambient Fuels, a leading hydrogen project developer. Rising demand for clean hydrogen in both the U.S. and E.U.
Brought to you by
To repurpose or use any of the content or material on this and our sister sites, explicit written permission needs to be sought.
